首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1510435

药用辅料市场规模- 按产品（有机、无机）、功能（黏合剂、悬浮剂和黏度剂、填充剂和稀释剂、防腐剂）配方（口服{片剂、胶囊}、液体、肠胃外、外用）和预测，2024 - 2032

Pharmaceutical Excipients Market Size - By Product (Organic, Inorganic), Functionality (Binder, Suspension & Viscosity Agents, Filler & Diluent, Preservatives) Formulation (Oral {Tablet, Capsule}, Liquid, Parenteral, Topical) & Forecast, 2024 - 2032

出版日期: 2024年04月01日 | 出版商:

Global Market Insights Inc. | 英文 285 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024 年至2032 年间，药用辅料市场规模的复合年增长率将超过8%。增强药物配方。这些赋形剂可提高活性药物成分的稳定性、溶解度和生物利用度，最终提高药物製剂的功效。新药物输送技术的出现也为原料製造商提供了满足不断变化的生产需求的机会。

合约开发和製造组织活动的增加将刺激市场扩张。外包使公司能够专注于研发，同时利用 CDMO/CMO 的专业知识和基础设施进行药物生产。药品生产的法律标准要求来自可靠供应商的高品质补充剂，进一步增加了产品需求。例如，2023 年 10 月，科莱恩推出了三种新的 VitiPure(R) 赋形剂，以增强 API 配方，特别是针对 mRNA 疫苗和生物製剂等精緻产品。

药用辅料产业分为产品、功能、配方和地区。

根据产品，到 2032 年，无机化学品领域的市场价值预计将增长 7.9%。它们具有高水平的纯度、稳定性以及与活性成分的相容性。界面活性剂提供独特的功能特性，例如控制释放和结合。无机添加剂，如盐、矿物质和金属，也可用于定製配方以满足特定要求。

由于注射药物的配方和输送的独特要求，预计 2024 年至 2032 年，注射剂领域的药用辅料市场复合年增长率将达到 7.9%。注射剂和静脉注射药物等肠外产品需要添加剂以确保稳定性以及与活性成分的相容性。赋形剂对于提高溶解度、控制输送以及满足清洁度和纯度监管标准至关重要。由于慢性病盛行率不断上升以及对标靶治疗的强烈需求，肠外给药的需求持续上升，对关键基础设施的优质开发商的需求不断增加，有利于该细分市场的成长。

亚太地区药用辅料产业将实现令人瞩目的成长，到2032 年复合年增长率为8.4%。推动对辅料的需求。对医疗保健基础设施的投资和慢性病的增加也增加了亚太地区对辅料的需求。

产业生态系统分析
产业影响力
- 成长动力
  - 对药品和仿製药的需求不断增长
  - 辅料的开发进展
  - 专利到期导致对辅料的需求增加
  - 加强製药公司的伙伴关係和合作
- 产业陷阱与挑战
  - 辅料的不良反应
  - 缺乏适当的审批流程
成长潜力分析
定价分析
技术分析
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
有机化学品
- 油脂化学品
  - 脂肪醇
  - 矿物硬脂酸盐
  - 甘油
  - 其他油脂化学品
- 碳水化合物
  - 糖
    - 实际糖分
    - 糖醇
    - 人工甜味剂
  - 纤维素
    - 微晶纤维素
    - 纤维素醚
    - CMC & 交联羧甲基纤维素钠
    - 纤维素酯
  - 淀粉
    - 变性淀粉
    - 干淀粉
    - 变性淀粉
- 石化产品
  - 乙二醇
  - 矿物碳氢化合物
  - 丙烯酸聚合物
  - 其他石化产品
- 蛋白质
- 其他有机化学品
无机化学品
- 磷酸钙
- 金属氧化物
- 岩盐
- 碳酸钙
- 硫酸钙
- 其他无机化学品
其他产品

第 6 章：市场估计与预测：按功能划分，2021 - 2032 年

主要趋势
活页夹
悬浮剂和增粘剂
助流剂
防腐剂
填充剂和稀释剂
润滑剂
乳化剂
崩解剂
其他功能

第 7 章：市场估计与预测：按配方划分，2021 - 2032 年

主要趋势
口服
- 药片
- 胶囊
  - 硬明胶
  - 软明胶
- 其他口服製剂
液体
注射用
专题
其他配方

第 8 章：市场估计与预测：按地区，2021 - 2032

主要动向：按地区
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 9 章：公司简介

Air Liquide S.A.
Archer Daniels Midland Company
Ashland
Associated British Foods PLC
BASF SE
Croda International PLC
Evonik Industries AG
Innophos
Kerry Group plc
Merck KGaA

简介目录

Product Code: 8780

Pharmaceutical excipients market size is estimated to register over 8% CAGR between 2024 and 2032. With the rising demand for dietary supplements alongside the increasing need for pharmaceuticals, excipients have grown essential as they help in enhancing drug formulations. These excipients improve stability, solubility, and bioavailability of active pharmaceutical ingredients, ultimately boosting the efficacy of drug formulations. The emergence of new drug delivery technologies is also presenting an opportunity for ingredient manufacturers to cater to evolving production needs.

Increased activities in contract development and manufacturing organizations will spur the market expansion. Outsourcing allows companies to focus on R&D while utilizing the expertise and infrastructure of CDMOs/CMOs for drug production. Legal standards for drug manufacturing require high-quality supplements from reliable suppliers, further boosting the product demand. For instance, in October 2023, Clariant launched three new VitiPure(R) excipients to enhance API formulations, especially for delicate products like mRNA vaccines and biologics.

The pharmaceutical excipients industry is segmented into product, functionality, formulation and region.

Based on product, the market value from the inorganic chemicals segment is projected to witness 7.9% growth rate through 2032. Inorganic chemicals are essential for pharmaceutical formulations to maintain quality and potency. They offer high levels of purity, stability, and compatibility with active ingredients. Surfactants provide unique functional properties like controlled release and binding. Inorganic additives, such as salts, minerals, and metals can also be used to customize formulations to meet specific requirements.

Pharmaceutical excipients market from the parenteral segment is anticipated to observe 7.9% CAGR from 2024 to 2032, owing to unique requirements for formulation and delivery of injectable pharmaceuticals. Parenteral products like injections and IV medications need additives for stability and compatibility with the active ingredient. Excipients are crucial in improving solubility, controlling delivery, and meeting regulatory standards for cleanliness and purity. As the demand for parenteral drug delivery continues to rise due to the increasing prevalence of chronic diseases and strong need for targeted therapies, the demand for quality developers for key infrastructure is increasing, favoring the segment growth.

Asia Pacific pharmaceutical excipients industry will record impressive growth, depicting an 8.4% CAGR through 2032. The expansion of the pharmaceutical industry in developing countries like China, India, and Southeast Asian countries is driving the demand for excipients due to increased healthcare infrastructure and spending, as well as the rising need for affordable medicines. Investments in healthcare infrastructure and increasing chronic diseases are also contributing to the need for excipients in APAC.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing demand for pharmaceutical and generic drugs
  - 3.2.1.2 Advancement in development of excipients
  - 3.2.1.3 Increased demand for excipients due to expiration of patents
  - 3.2.1.4 Increasing partnership and collaboration of pharmaceutical companies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Adverse effects of excipients
  - 3.2.2.2 Lack of proper approval process
3.3 Growth potential analysis
3.4 Pricing analysis
3.5 Technology analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Organic chemicals
- 5.2.1 Oleochemicals
  - 5.2.1.1 Fatty alcohols
  - 5.2.1.2 Mineral stearates
  - 5.2.1.3 Glycerin
  - 5.2.1.4 Other oleochemicals
- 5.2.2 Carbohydrates
  - 5.2.2.1 Sugar
    - 5.2.2.1.1 Actual sugar
    - 5.2.2.1.2 Sugar alcohols
    - 5.2.2.1.3 Artificial sweeteners
  - 5.2.2.2 Cellulose
    - 5.2.2.2.1 Microcrystalline cellulose
    - 5.2.2.2.2 Cellulose ethers
    - 5.2.2.2.3 CMC & croscarmellose sodium
    - 5.2.2.2.4 Cellulose esters
  - 5.2.2.3 Starch
    - 5.2.2.3.1 Modified starch
    - 5.2.2.3.2 Dried starch
    - 5.2.2.3.3 Converted starch
- 5.2.3 Petrochemicals
  - 5.2.3.1 Glycols
  - 5.2.3.2 Minerals hydrocarbons
  - 5.2.3.3 Acrylic polymers
  - 5.2.3.4 Other petrochemicals
- 5.2.4 Proteins
- 5.2.5 Other organic chemicals
5.3 Inorganic chemicals
- 5.3.1 Calcium phosphate
- 5.3.2 Metal oxides
- 5.3.3 Halites
- 5.3.4 Calcium carbonate
- 5.3.5 Calcium sulfate
- 5.3.6 Other inorganic chemicals
5.4 Other products

Chapter 6 Market Estimates and Forecast, By Functionality, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Binder
6.3 Suspension and viscosity agents
6.4 Glidants
6.5 Preservatives
6.6 Filler & diluent
6.7 Lubricant
6.8 Emulsifier
6.9 Disintegrant
6.10 Other functionalities

Chapter 7 Market Estimates and Forecast, By Formulation, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Oral
- 7.2.1 Tablet
- 7.2.2 Capsule
  - 7.2.2.1 Hard gelatin
  - 7.2.2.2 Soft gelatin
- 7.2.3 Other oral formulations
7.3 Liquid
7.4 Parenteral
7.5 Topical
7.6 Other formulations

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa